Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
J Vasc Surg ; 74(1): 1-4, 2021 07.
Article in English | MEDLINE | ID: covidwho-1198951

ABSTRACT

OBJECTIVE: To assess the introduction of telemedicine as an alternative to the traditional face-to-face encounters with vascular surgery patients in the era of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: A retrospective review of prospectively collected data on face-to-face and telemedicine interactions was conducted at a multisite health care system from January to August 2020 in vascular surgery patients during the COVID-19 pandemic. The end point is direct patient satisfaction comparison between face-to-face and telemedicine encounters/interactions prior and during the pandemic. RESULTS: There were 6262 patient encounters from January 1, 2020, to August 6, 2020. Of the total encounters, 790 (12.6%) were via telemedicine, which were initiated on March 11, 2020, after the World Health Organization's declaration of the COVID-19 pandemic. These telemedicine encounters were readily adopted and embraced by both the providers and patients and remain popular as an option to patients for all types of visits. Of these patients, 78.7% rated their overall health care experience during face-to-face encounters as very good and 80.6% of patients rated their health care experience during telemedicine encounters as very good (P = .78). CONCLUSIONS: Although the COVID-19 pandemic has produced unprecedented consequences to the practice of medicine and specifically of vascular surgery, our multisite health care system has been able to swiftly adapt and adopt telemedicine technologies for the care of our complex patients. Most important, the high quality of patient-reported satisfaction and health care experience has remained unchanged.


Subject(s)
COVID-19/epidemiology , Specialties, Surgical/standards , Telemedicine/methods , Vascular Diseases/surgery , Vascular Surgical Procedures/methods , Comorbidity , Health Care Surveys , Humans , Pandemics , Patient Satisfaction , Retrospective Studies , SARS-CoV-2 , Vascular Diseases/epidemiology
2.
Sultan Qaboos Univ Med J ; 21(1): e116-e119, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-1156224

ABSTRACT

OBJECTIVES: This study aimed to discuss the different challenges faced while managing emergency vascular surgery cases during the COVID-19 pandemic and how these challenges were overcome. METHODS: This study details 14 emergency cases that were managed during a period of one month from mid-March to mid-April at Sultan Qaboos University Hospital, Muscat, Oman. The cases included acute limb ischaemia, critical limb ischaemia, type B dissection of the thoracic aorta, thoraco-abdominal aneurysm, critical internal carotid artery stenosis, trauma, infected arteriovenous forearm loop graft and thrombosed arteriovenous fistulas. RESULTS: Only one patient was confirmed to have COVID-19. Five were negative for COVID-19 while the remaining eight were not tested. Various strategies on how the vascular surgical team accommodated changes in hospital protocols and nationwide lockdown are discussed in detail. CONCLUSIONS: With the judicious use of personal protective equipment and consumable surgical and endovascular devices, communication with support services and other hospitals and implementation of triage protocols, it was possible to manage vascular surgery emergencies effectively.


Subject(s)
COVID-19/diagnosis , Emergencies , Referral and Consultation , Vascular Diseases/therapy , Vascular Surgical Procedures/methods , Adult , Aged , Aged, 80 and over , Amputation/methods , Aneurysm, Dissecting/therapy , Angioplasty/methods , Aortic Aneurysm/therapy , Arteriovenous Shunt, Surgical , COVID-19/complications , Carotid Stenosis/therapy , Disease Management , Embolectomy/methods , Female , Graft Occlusion, Vascular/complications , Graft Occlusion, Vascular/therapy , Humans , Ischemia/therapy , Lower Extremity , Male , Middle Aged , Oman , SARS-CoV-2 , Tertiary Care Centers , Upper Extremity
3.
J Card Surg ; 36(3): 848-856, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1029257

ABSTRACT

BACKGROUND: A significant restructuring of the healthcare services has taken place since the declaration of the coronavirus disease 2019 (COVID-19) pandemic, with elective surgery put on hold to concentrate intensive care resources to treat COVID-19 as well as to protect patients who are waiting for relatively low risk surgery from exposure to potentially infected hospital environment. METHODS: Multicentre study, with 19 participating centers, to define the impact of the pandemic on the provision of aortovascular services and patients' outcomes after having adapted the thresholds for intervention to guarantee access to treatment for emergency and urgent conditions. Retrospective analysis of prospectively collected data, including all patients with aortovascular conditions admitted for surgical or conservative treatment from the 1st March to the 20th May 2020. RESULTS: A total of 189 patients were analyzed, and 182 underwent surgery. Diagnosis included: aneurysm (45%), acute aortic syndrome (44%), pseudoaneurysm (4%), aortic valve endocarditis (4%), and other (3%). Timing for surgery was: emergency (40%), urgent (34%), or elective (26%). In-hospital mortality was 12%. Thirteen patients were diagnosed with COVID-19 during the peri-operative period, and this subgroup was not associated with a higher mortality. CONCLUSIONS: There was a significant change in service provision for aortovascular patients in the UK. Although the emergency and urgent surgical activity were maintained, elective treatment was minimal during early months of the pandemic. The preoperative COVID-19 screening protocol, combined with self-isolation and shielding, contributed to the low incidence of COVID-19 in our series and a mortality similar to that of pre-pandemic outcomes.


Subject(s)
Aortic Diseases/surgery , COVID-19/epidemiology , Emergencies , Pandemics , SARS-CoV-2 , Vascular Surgical Procedures/methods , Adult , Aged , Aged, 80 and over , Aortic Diseases/epidemiology , Comorbidity , Emergency Service, Hospital , Female , Humans , Incidence , Male , Middle Aged , Retrospective Studies , United Kingdom/epidemiology
4.
Eur J Vasc Endovasc Surg ; 61(2): 306-315, 2021 02.
Article in English | MEDLINE | ID: covidwho-921971

ABSTRACT

OBJECTIVE: During the most aggressive phase of the COVID-19 outbreak in Italy, the Regional Authority of Lombardy identified a number of hospitals, named Hubs, chosen to serve the whole region for highly specialised cases, including vascular surgery. This study reports the experience of the four Hubs for Vascular Surgery in Lombardy and provides a comparison of in hospital mortality and major adverse events (MAEs) according to COVID-19 testing. METHODS: Data from all patients who were referred to the Vascular Surgery Department of Hubs from 9 March to 28 April 2020 were collected prospectively and analysed. A positive COVID-19 polymerase chain reaction swab test, or symptoms (fever > 37.5 °C, upper respiratory tract symptoms, chest pain, and contact/travel history) associated with interstitial pneumonia on chest computed tomography scan were considered diagnostic of COVID-19 disease. Patient characteristics, operative variables, and in hospital outcomes were compared according to COVID-19 testing. A multivariable model was used to identify independent predictors of in hospital death and MAEs. RESULTS: Among 305 included patients, 64 (21%) tested positive for COVID-19 (COVID group) and 241 (79%) did not (non-COVID group). COVID patients presented more frequently with acute limb ischaemia than non-COVID patients (64% vs. 23%; p < .001) and had a significantly higher in hospital mortality (25% vs. 6%; p < .001). Clinical success, MAEs, re-interventions, and pulmonary and renal complications were significantly worse in COVID patients. Independent risk factors for in hospital death were COVID (OR 4.1), medical treatment (OR 7.2), and emergency setting (OR 13.6). COVID (OR 3.4), obesity class V (OR 13.5), and emergency setting (OR 4.0) were independent risk factors for development of MAEs. CONCLUSION: During the COVID-19 pandemic in Lombardy, acute limb ischaemia was the most frequent vascular disease requiring surgical treatment. COVID-19 was associated with a fourfold increased risk of death and a threefold increased risk of major adverse events.


Subject(s)
COVID-19 , Infection Control , Postoperative Complications , Vascular Diseases , Vascular Surgical Procedures , Aged , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Testing/methods , COVID-19 Testing/statistics & numerical data , Emergencies/epidemiology , Emergency Service, Hospital/organization & administration , Emergency Service, Hospital/statistics & numerical data , Female , Hospital Mortality , Humans , Infection Control/methods , Infection Control/organization & administration , Italy/epidemiology , Male , Outcome and Process Assessment, Health Care , Postoperative Complications/epidemiology , Postoperative Complications/therapy , Prognosis , Retrospective Studies , Risk Adjustment/methods , Risk Factors , SARS-CoV-2/isolation & purification , Vascular Diseases/diagnosis , Vascular Diseases/mortality , Vascular Diseases/surgery , Vascular Surgical Procedures/adverse effects , Vascular Surgical Procedures/methods
5.
Interact Cardiovasc Thorac Surg ; 31(6): 834-840, 2020 12 07.
Article in English | MEDLINE | ID: covidwho-910371

ABSTRACT

OBJECTIVES: Our goal was to compare the short-term outcomes of Stanford type A aortic dissection (TAAD), during the coronavirus disease 2019 (COVID-19) pandemic with those during normal times and summarize our perioperative management experience of patients with TAAD in the context of COVID-19. METHODS: From 17 January 2020 to 8 March 2020, a total of 27 patients with TAAD were operated on in 8 cardiovascular surgery centres in Hubei Province (COVID-19 group). The data from 91 patients with TAAD from the same centres during the same period last year were extracted from the Hubei Cardiac Surgery Registration System (control group). A propensity score matched subgroup of 26 pairs (1:2) was identified. Perioperative data and short-term outcomes were assessed. RESULTS: Nine patients in the COVID-19 group were categorized as suspicious for the disease (9/27, 33.3%), and others were excluded (18/27, 66.7%). No one was laboratory confirmed preoperatively. The average waiting, cross-clamp and circulatory arrest times were longer in the COVID-19 group (22.9 ± 8.3 vs 9.7 ± 4.0 h, P < 0.001; 135 ± 36 vs 103 ± 45 min, P = 0.003; 24 ± 9 vs 17 ± 8 min, P < 0.001, respectively). The 30-day or in-hospital deaths were 3.8% in both groups (P = 1.0). The COVID-19 group was associated with longer ventilation and intensive care unit times (81 ± 71 vs 45 ± 19 h, P < 0.001; 7.4 ± 3.8 vs 4.5 ± 2.7 days; P < 0.001, respectively). There were no statistical differences between the 2 groups in the incidence of complications such as stroke, neurological deficit, acute kidney injury, pulmonary infection and reoperation. Serum antibody tests for those patients showed 7 out of 9 suspected cases were Immunoglobulin G positive. No cross-infection occurred in other patients or associated medical staff. CONCLUSIONS: With adequate preparation and appropriate protection, satisfactory early outcomes can be achieved after emergency operations for patients with TAAD during the COVID-19 pandemic.


Subject(s)
Aneurysm, Dissecting/surgery , COVID-19/epidemiology , Pandemics , Propensity Score , SARS-CoV-2 , Vascular Surgical Procedures/methods , Aneurysm, Dissecting/epidemiology , China/epidemiology , Comorbidity , Female , Humans , Incidence , Intensive Care Units , Male , Middle Aged , Reoperation , Retrospective Studies , Risk Factors , Survival Rate/trends , Time Factors , Treatment Outcome
7.
Int Wound J ; 17(6): 1863-1870, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-724544

ABSTRACT

When diabetes mellitus is not properly controlled with drugs and a healthy lifestyle, it exposes patients with advanced peripheral arterial disease or critical limb ischaemia (CLI) to the most serious complications, in particular lower limb ulcers. Surgical or endovascular treatments represent the first line of intervention; in addition, the adequate management of ulcers can guarantee not only a faster wound healing but also the improvement of the patient's prognosis. To speed up this process, negative pressure wound therapy (NPWT), platelet-rich plasma (PRP), and other advanced moist wound dressing have been proposed. During Coronavirus disease 2019 (COVID-19) pandemic, many patients with CLI and diabetes mellitus had difficult access to advanced treatments with a significant reduction in life expectancy. We report the cases of patients with non-healing ulcers and CLI treated with an empiric multistage approach after successful endovascular revascularisation; the postoperative course was eventful in all patients, and foot ulcers are currently in an advanced state of healing. The association between adequate revascularisation, systemic anti-inflammatory, and antibiotic therapy with the multistage advanced medications ensures healing of ulcers, limb salvage, and improvement of patient prognosis.


Subject(s)
Bandages , COVID-19/epidemiology , Diabetic Foot/therapy , Negative-Pressure Wound Therapy/methods , Reconstructive Surgical Procedures/methods , Vascular Surgical Procedures/methods , Wound Healing , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Comorbidity , Diabetic Foot/epidemiology , Humans , Male , Pandemics , Platelet-Rich Plasma , SARS-CoV-2
9.
J Card Surg ; 35(10): 2832-2834, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-645775

ABSTRACT

The nuance of operative decision making for those in need of emergent operation during coronavirus disease 2019 (COVID-19) pandemic is increasingly complex in the absence of robust data or guidelines. We present two cases of thoracic aortic emergencies with COVID-19 disease who survived high-risk operations to highlight the potential for successful outcomes even in situations compounding patient disease, morbid operation, and the added risk associated with virulent disease in the pandemic time.


Subject(s)
Aneurysm, Dissecting/surgery , Aorta, Thoracic/surgery , Aortic Aneurysm, Thoracic/surgery , Betacoronavirus , Coronavirus Infections/epidemiology , Emergencies , Pneumonia, Viral/epidemiology , Vascular Surgical Procedures/methods , Aged, 80 and over , Aneurysm, Dissecting/diagnosis , Aneurysm, Dissecting/epidemiology , Aortic Aneurysm, Thoracic/diagnosis , Aortic Aneurysm, Thoracic/epidemiology , COVID-19 , Comorbidity , Female , Humans , Male , Middle Aged , Pandemics , Postoperative Period , Preoperative Period , SARS-CoV-2 , Tomography, X-Ray Computed
12.
Eur J Vasc Endovasc Surg ; 60(1): 127-134, 2020 07.
Article in English | MEDLINE | ID: covidwho-537912

ABSTRACT

OBJECTIVE: This study aimed to evaluate the protocol adopted during the emergency phase of the COVID-19 pandemic to maintain elective activity in a vascular surgery unit while minimising the risk of contamination to both patients and physicians, and the impact of this activity on the intensive care (IC) resources. METHODS: The activity of a vascular surgery unit was analysed from 8 March to 8 April 2020. Surgical activity was maintained only for acute or elective procedures obeying priority criteria. The preventive screening protocol consisted of nasopharyngeal swabs (NPS) for all patients and physicians with symptoms and for unprotected contact infected cases, and serological physician evaluations every 15 days. Patients treated in the acute setting were considered theoretically infected and the necessary protective devices were used. The number of patients and the possible infection of physicians were evaluated. The number and type of interventions and the need for post-operative IC during this period were compared with those in the same periods in 2018 and 2019. RESULTS: One hundred and fifty-one interventions were performed, of which 34 (23%) were acute/emergency. The total number of interventions was similar to those performed in the same periods in 2019 and 2018: 150 (33, of which 22% acute/emergency) and 117 (29, 25% acute/emergency), respectively. IC was necessary after 6% (17% in 2019 and 20% in 2018) of elective operations and 33% (11) of acute/emergency interventions. None of the patients treated electively were diagnosed with COVID-19 infection during hospitalisation. Of the 34 patients treated in acute/emergency interventions, five (15%) were diagnosed with COVID-19 infection. It was necessary to screen 14 (47%) vascular surgeons with NPS after contact with infected colleagues, but none for unprotected contact with patients; all were found to be negative on NPS and serological evaluation. CONCLUSION: A dedicated protocol allowed maintenance of regular elective vascular surgery activity during the emergency phase of the COVID-19 pandemic, with no contamination of patients or physicians and minimal need for IC resources.


Subject(s)
Coronavirus Infections , Elective Surgical Procedures , Emergency Service, Hospital , Infection Control , Pandemics , Pneumonia, Viral , Vascular Diseases , Vascular Surgical Procedures , Adult , Betacoronavirus/isolation & purification , COVID-19 , Clinical Protocols , Comorbidity , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Critical Pathways/trends , Elective Surgical Procedures/methods , Elective Surgical Procedures/statistics & numerical data , Emergency Service, Hospital/organization & administration , Emergency Service, Hospital/statistics & numerical data , Female , Humans , Infection Control/methods , Infection Control/organization & administration , Italy/epidemiology , Male , Middle Aged , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Program Evaluation , SARS-CoV-2 , Vascular Diseases/epidemiology , Vascular Diseases/surgery , Vascular Surgical Procedures/methods , Vascular Surgical Procedures/statistics & numerical data
13.
Rev. Col. Bras. Cir ; 47: e20202595, 2020. tab
Article in English | WHO COVID, LILACS (Americas) | ID: covidwho-531877

ABSTRACT

ABSTRACT The New Coronavirus Epidemic (2019-nCoV), discovered in the city of Wuhan, China, in December 2019, presents mainly with pulmonary pneumonia that is preceded by fever, cough and myalgia. However, as the disease spread globally and the number of hospitalizations increased exponentially, it was noted that most serious patients hospitalized by COVID-19 have laboratory changes worthy of attention, such as lymphopenia, neutrophilia, increased time of prothrombin and increased levels of D-dimer. Due to these changes proving to be crucial for the mortality and morbidity rates in this subset of infected people, several studies focusing on the pathophysiology, mainly hematological, of the disease appear every day. Deepening these studies, several published works have shown SarsCoV-2 infection to the installation of a prothrombotic state in hospitalized patients, which leads to the potential occurrence of thrombotic or arterial events in this cohort. Thus, in order to understand how the departments of Angiology and Vascular Surgery are acting in the context of the COVID-19 pandemic, this work aims to gather studies that reveal from protocols applied in vascular services in the current situation, until to the role of vascular surgeons and angiologists in the clinical and surgical management of patients infected or not, as a way of helping and clarifying this specialty during the context of a pandemic due to the new coranavirus. For the selection of works, the following search criteria were used: "Coronavirus and venous thrombosis", "Coronavirus and thrombosis", "COVID-19 and venous thrombosis" and "COVID-19 Coronavirus and thrombosis".


RESUMO A epidemia pelo novo Coronavirus (2019-nCoV), surgido na cidade de Wuhan, na China, em dezembro de 2019, quando sintomática, apresenta-se majoritariamente por um quadro de pneumonia pulmonar que é precedida por febre, tosse seca e mialgia. No entanto, conforme a doença se espalhou globalmente e o número de hospitalizações aumentaram de forma exponencial, notou-se que a maior parte dos pacientes graves internados por COVID-19 possuem alterações laboratoriais dignas de atenção, como linfopenia, neutrofilia, aumento do tempo de protrombina e elevação dos níveis de D-dímero. Devido tais mudanças se mostrarem cruciais para a taxa de mortalidade e morbidade nesse subgrupo de infectados, diversos trabalhos com enfoque na fisiopatologia, principalmente hematológica, da doença surgem a cada dia. Aprofundando em tais estudos, variados trabalhos publicados evidenciaram a infecção pelo Sars-CoV-2 à instalação de um estado pró-trombótico em pacientes hospitalizados graves, o que acarreta em potencial ocorrência de eventos trombóticos venosos ou arteriais nessa coorte. Assim, para entender como os Departamentos de Angiologia e Cirurgia Vascular estão atuando no contexto da pandemia de COVID-19, este estudo tem por objetivo reunir estudos que revelam desde protocolos aplicados nos serviços vasculares na atual conjuntura, até a atuação dos cirurgiões vasculares e angiologistas no manejo clínico e cirúrgico de pacientes infectados ou não, como forma de ajudar e esclarecer essa especialidade durante o contexto de pandemia pelo novo coronavírus. Para a seleção dos trabalhos foram utilizados os seguintes critérios de busca: "Coronavirus and venous thrombosis", "Coronavirus and thrombosis", "COVID-19 and venous thrombosis" e "COVID-19 Coronavirus and thrombosis".


Subject(s)
Humans , Pneumonia, Viral/complications , Pulmonary Embolism/virology , Thromboembolism/virology , Coronavirus Infections/complications , Pandemics , Betacoronavirus , Pneumonia, Viral/physiopathology , Pulmonary Embolism/diagnosis , Pulmonary Embolism/therapy , Thromboembolism/therapy , Vascular Surgical Procedures/methods , Vascular Surgical Procedures/standards , Blood Coagulation/physiology , Clinical Protocols , Coronavirus Infections/physiopathology , SARS-CoV-2 , COVID-19
17.
Ann Thorac Surg ; 110(5): e405-e407, 2020 11.
Article in English | MEDLINE | ID: covidwho-102386

ABSTRACT

As of April 7, 2020, approximately 1,300,000 cases and 80,000 deaths related to coronavirus disease 2019 (COVID-19) have been reported in more than 180 countries/territories. Health care infrastructures and resources, particularly as it relates to the care of the most critically ill patients, are currently being strained globally. In this context, however, there has been little clinical guidance or information regarding life-threatening conditions requiring emergency operation that cannot be delayed. We present a case of acute type A aortic dissection in a patient with COVID-19 to highlight the clinical implications of a true emergent procedure during the COVID-19 outbreak.


Subject(s)
Aneurysm, Dissecting/etiology , Aortic Aneurysm, Thoracic/etiology , Betacoronavirus , Coronavirus Infections/complications , Pneumonia, Viral/complications , Vascular Surgical Procedures/methods , Aneurysm, Dissecting/diagnosis , Aneurysm, Dissecting/surgery , Aortic Aneurysm, Thoracic/diagnosis , Aortic Aneurysm, Thoracic/surgery , COVID-19 , Fatal Outcome , Humans , Male , Middle Aged , Pandemics , SARS-CoV-2 , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL